KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice - Wikidata - awgldk - TriplyDB

KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice

KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice

http://www.wikidata.org/entity/Q33759960

about

In situ mutation detection and visualization of intratumor heterogeneity for cancer research and diagnostics Allele specific locked nucleic acid quantitative PCR (ASLNAqPCR): an accurate and cost-effective assay to diagnose and quantify KRAS and BRAF mutation Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing.KRAS genotyping in rectal adenocarcinoma specimens with low tumor cellularity after neoadjuvant treatment.KRAS mutation analysis by PCR: a comparison of two methods.High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort.Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future.Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma.A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens.Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform.KRAS Testing: A Tool for the Implementation of Personalized Medicine.N-ras mutation detection by pyrosequencing in adult patients with acute myeloid leukemia at a single institution Current and future molecular diagnostics in colorectal cancer and colorectal adenoma.Molecular Testing for Gastrointestinal Cancer.KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs and beyond.Predicting tumour response.454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples.Targeted sequencing with enrichment PCR: a novel diagnostic method for the detection of EGFR mutations.Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort.Ameloblastoma RNA profiling uncovers a distinct non-coding RNA signature.Novel biotechnology approaches in colorectal cancer diagnosis and therapy.Current companion diagnostics in advanced colorectal cancer; getting a bigger and better piece of the pie Preparation of DNA from cytological material: effects of fixation, staining, and mounting medium on DNA yield and quality.Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.Sensitive High-Resolution Melting Analysis for Screening of KRAS and BRAF Mutations in Iranian Human Metastatic Colorectal Cancers AdvISER-PYRO: Amplicon Identification using SparsE Representation of PYROsequencing signal.Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients.Fidelity of RNA templated end-joining by chlorella virus DNA ligase and a novel iLock assay with improved direct RNA detection accuracy.Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer.The usability of allele-specific PCR and reverse-hybridization assays for KRAS genotyping in Serbian colorectal cancer patients.Tumour molecular profiling for deciding therapy-the French initiative.Molecular Biomarkers for the Evaluation of Colorectal Cancer.Consistent mutation status within histologically heterogeneous lung cancer lesions.

P2860

Q28658975-072B3A37-87EC-4E3B-A130-85B8D185A8BC Q28730199-72578E7F-26AA-496B-91CF-747DD774B26D Q33732199-94499E36-6BC5-4A4B-830C-83FB3D49FE2C Q33875090-D8781718-396E-46D4-B483-286AF19BA18D Q34142761-F00EBDCB-5691-4B98-936B-D3BDD6D58EF8 Q34876437-A3BB1477-74AB-492C-AFEC-58A6E0E149C4 Q35677169-343BBDDE-9095-4EF6-8D0E-3C1AB7614633 Q35920508-F02CC3FC-27D7-4DA8-8E54-9781AB782D8F Q36088709-ED796D1D-B1E2-418C-9A7E-DB6FDA3E286F Q36089983-E5D95E43-5CB1-4B0C-9193-AFF746EB76BD Q36377976-1C822280-E238-4B5B-9A59-3434CAF95EF1 Q36481945-9CD39B3A-E741-4AF4-8E7B-73C61CC776A8 Q36821796-486BADD1-5938-49EA-BC20-58A8B81948D7 Q37697538-19D606B1-89B3-43E5-ADA2-54E54930C46E Q37710556-808E3597-4ACC-4570-97DB-79FFE6A8449F Q38136134-E3865E15-6CB0-482F-BF1F-F2B5FED401B8 Q38141699-CEE6E4D3-F897-4921-9969-B5D3C2CF640F Q38395259-7732EC66-717F-4734-8865-87A8BE710C4D Q38882001-64C245F9-B80E-4733-B9C1-90F24EED6C45 Q39094258-5F9DFF9C-68EC-410F-868B-CA21F7D205E4 Q39103785-E1FC114A-9711-4297-BCE2-F30F80C364D3 Q39151211-E6488D52-88DA-4AEB-85AF-BD642F2B5BD9 Q39172118-4C4D1AB8-91F0-431D-AE3B-567590C4445D Q39194738-14A38642-D0BF-4B0A-AFEF-A5AA048D20CD Q40341349-C9D650A9-FB4B-4D3D-81C3-11248164AACF Q40364772-72DD1D56-C43E-4174-B931-A5FB971891C1 Q42088307-08AA7EA2-AA54-49A2-B614-65EB34F5AB82 Q42183079-5F65306A-3B51-4D9E-A5C1-75E5FB53A173 Q45326052-9916A3B3-AB8E-487B-B6ED-948C1C8E09E9 Q45376093-3E968E64-81BC-4C9F-BC8C-92EC69E9FAB8 Q46700404-8C9D08F6-A912-40F9-B2FB-A07E4748BA21 Q50929302-4196447E-4F77-4A0A-9327-76CF2C5BD100 Q52794464-A2B7C547-D949-4224-880E-D41E3A266029 Q54520483-A3CD48E1-1B36-440E-AFA2-64DACE6C415F

P2860

KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice

http://www.wikidata.org/entity/Q33759960

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

KRAS analysis in colorectal ca ...... cific PCR in clinical practice

@ast

KRAS analysis in colorectal ca ...... cific PCR in clinical practice

@en

type

label

KRAS analysis in colorectal ca ...... cific PCR in clinical practice

@ast

KRAS analysis in colorectal ca ...... cific PCR in clinical practice

@en

prefLabel

KRAS analysis in colorectal ca ...... cific PCR in clinical practice

@ast

KRAS analysis in colorectal ca ...... cific PCR in clinical practice

@en

P1433

Q33759960-18C4142E-F9AC-4DAD-A88F-648DFAC4051E

P1476

Q33759960-762766DD-5643-481E-867D-5F547D4B3BD6

P2093

Q33759960-1C8D1EE5-5AB9-4BB5-B427-59388487C48A

Q33759960-340A0CA8-A32B-46E4-BB03-7629E364577B

Q33759960-68B22D97-0B21-4D72-A262-04D2F2F5B409

Q33759960-7B46767C-418E-4CBA-AEC1-B9453F1ED14B

Q33759960-8741A424-29D4-4573-808A-9AE12E17278B

Q33759960-DFEFA6FF-9EAD-4313-B03C-0EAEFC104DA0

P2860

Q33759960-03F367F5-4897-4C69-8FB7-C7E069C853C3

Q33759960-10CEF43A-BC3B-4E00-9249-22307248B041

Q33759960-147DC4A7-DD1F-42BC-A644-A581DC9272B8

Q33759960-237CCC15-7E1B-47EC-B2C4-15AB2A154972

Q33759960-2EBDAA1D-D369-460F-B11A-31A6955517A5

Q33759960-317F0345-FAB2-4BE5-ACCB-9B5EBA210FA3

Q33759960-370AB39A-1D1A-4AD4-AFF5-E2F80A5CD555

Q33759960-38446944-8469-4364-91EE-4DABEE10EF79

Q33759960-3BC73916-409B-4AB3-948E-287A52005351

Q33759960-41AFAD71-A6AB-4037-891E-FDAD5CFE21D1

P2888

Q33759960-794BACA6-60DF-44A3-BDBE-A878A3D99403

P304

Q33759960-A6D62990-A041-4960-915E-9D23270A2EB9

P31

Q33759960-03B353F8-F458-4013-B1D0-6C5A6FA92419

P356

Q33759960-808A29DB-7D24-4E5B-B6D6-D94BFFA7A1C3

P407

Q33759960-FD6A06F0-589A-4428-A3B5-497E01091669

P478

Q33759960-24AF7329-4501-4690-85A3-015389EC1257

P50

Q33759960-D3C0259C-DA2A-49D0-B616-9EBF95F0677D

P577

Q33759960-C6BCBAD0-2047-49C5-833B-9206510C153B

P5875

Q33759960-343F375E-55ED-4FA4-A004-8E7E9009F82B

P6179

Q33759960-C86CDCA5-B800-44E7-ADE9-C84E1CE2B615

P698

Q33759960-E7BD87BB-B5A7-440B-AF6B-B22EBCB0137A

P932

Q33759960-3943DD3E-FC54-43AB-A6FA-8BD6E28D640A

P356

1471-2407-10-660

P1433

P1476

KRAS analysis in colorectal ca ...... cific PCR in clinical practice

@en

P2093

Helgi Birgisson

http://www.w3.org/2001/XMLSchema#string

Johan Botling

http://www.w3.org/2001/XMLSchema#string

Karolina Edlund

http://www.w3.org/2001/XMLSchema#string

Magnus Sundström

http://www.w3.org/2001/XMLSchema#string

Monica Lindell

http://www.w3.org/2001/XMLSchema#string

Patrick Micke

http://www.w3.org/2001/XMLSchema#string

P2860

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

A sequencing method based on real-time pyrophosphate

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

ras oncogenes in human cancer: a review

Fast simultaneous detection of K-RAS mutations in colorectal cancer.

P2888

1471-2407-10-660

P304

660

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-10-660

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Bengt Glimelius

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49649392

http://www.w3.org/2001/XMLSchema#string

P6179

1019919527

http://www.w3.org/2001/XMLSchema#string

P698

21122130

http://www.w3.org/2001/XMLSchema#string

P932

3002357

http://www.w3.org/2001/XMLSchema#string